NCT01546558View on ClinicalTrials.gov

Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Metformin

Metformin 1000 mg bid on Days 1-10

DRUG

Ranolazine

Ranolazine 500 mg bid on Days 6-10

Trial Locations (1)

33126

SeaView Research Inc., Miami

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT01546558 - Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg | Biotech Hunter | Biotech Hunter